$IMXI

International Money Express (IMXI) executive stock withheld to cover RSU taxes

International Money Express (IMXI) executive Joseph Aguilar had 2,026 shares of common stock withheld on February 28, 2026, to cover tax obligations related to restricted stock unit vesting. The shares were valued at $15.78 each. Following these transactions, Aguilar retains direct ownership of over 145,000 shares.

Original reporting
Published Mar 3, 2026, 10:18 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 3, 2026, 11:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$IMXI
Neutral
medium confidence
Mentioned
$IMXI
alphai data visualization · based on Stock Titan
Decision brief

The 30-second read

$IMXINeutralLow
01

Why it matters

This transaction is a routine tax-related activity and is unlikely to influence stock price significantly.

02

Market read

The news has limited impact on market perception; primarily relevant for investors monitoring insider activity.

03

What to watch

Tax obligations are routine; the transaction does not necessarily reflect on company fundamentals.

Timing: short-term

Background

International Money Express (IMXI) reported that an executive withheld shares to cover RSU tax obligations, a common practice among insiders.

Company-level read

Ticker impact

$IMXINeutralMedium confidence
Context

The news pertains to insider stock withholding related to RSU tax obligations, which may influence investor perception of management's confidence.

Expected impact

Minimal short-term impact; potential slight positive bias due to insider confidence.

Evidence & confidence

Insider transactions are common and may not directly correlate with stock performance; the net effect is likely neutral.

Market effects

Limited; the transaction is specific to company management and does not indicate sector-wide changes.

negligible

negligible

Counterpoint

Some investors may interpret insider withholding as a sign of upcoming stock dilution or management's lack of confidence.

Key entities

  • Joseph Aguilar

    Executive of IMXI involved in the transaction.

Related articles

$WUMedAI 8/10

Western Union Company and International Money Express, Inc. Receive Regulatory Approval from New York State Department of Financial Services for Pending Acquisition

Western Union and International Money Express said New York State’s Department of Financial Services approved Western Union’s pending acquisition of Intermex. Western Union also made commitments to the regulator regarding remittance services and New York locations after the deal, according to the companies.

$WUMedAI 8/10

Western Union and Intermex Provide Update on Pending Acquisition

Western Union (NYSE: WU) and Intermex (NASDAQ: IMXI) said they received regulatory approval from New York’s DFS for Western Union’s pending acquisition of Intermex. They also reported a California DFPI letter suspending a previously granted approval extension, citing a need for further review. The companies plan to engage with DFPI to seek reinstatement and close after remaining conditions.

$WUMedAI 8/10

The Western Union Company: Western Union and Intermex Provide Update on Pending Acquisition

Western Union (NYSE: WU) and Intermex (NASDAQ: IMXI) updated on regulatory steps for Western Union’s pending acquisition of Intermex. NYDFS approved the deal and Western Union made commitments for New York remittance services and locations. Separately, California DFPI suspended an approval extension and the firms plan to seek reinstatement before closing.

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.